{"id":"https://openalex.org/W4380152962","doi":"https://doi.org/10.1177/13524585231179108","title":"Rectifying global inequities in neuromyelitis optica diagnosis and treatment","display_name":"Rectifying global inequities in neuromyelitis optica diagnosis and treatment","publication_year":2023,"publication_date":"2023-06-10","ids":{"openalex":"https://openalex.org/W4380152962","doi":"https://doi.org/10.1177/13524585231179108","pmid":"https://pubmed.ncbi.nlm.nih.gov/37300419"},"language":"en","primary_location":{"id":"doi:10.1177/13524585231179108","doi":"https://doi.org/10.1177/13524585231179108","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585231179108","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585231179108?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585231179108?download=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062928592","display_name":"Farrah Jasmine Mateen","orcid":"https://orcid.org/0000-0002-4293-8115","observed_orcids":["https://orcid.org/0000-0002-4293-8115"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Farrah J Mateen","raw_affiliation_strings":["Department of Neurology, Massachusetts General Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-4293-8115","affiliations":[{"raw_affiliation_string":"Department of Neurology, Massachusetts General Hospital, Boston, MA, USA/Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062928592"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.9912,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.73410658,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"29","issue":"8","first_page":"932","last_page":"935"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuromyelitis-optica","display_name":"neuromyelitis optica","score":1.0},{"id":"https://openalex.org/keywords/global-health-inequities","display_name":"global health inequities","score":0.847000002861023},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/access-to-treatment","display_name":"access to treatment","score":0.6869999766349792},{"id":"https://openalex.org/keywords/diagnosis","display_name":"diagnosis","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C2781137167","wikidata":"https://www.wikidata.org/wiki/Q611458","display_name":"Neuromyelitis optica","level":3,"score":0.9413459300994873},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8172417879104614},{"id":"https://openalex.org/C187029079","wikidata":"https://www.wikidata.org/wiki/Q958679","display_name":"Cognitive reframing","level":2,"score":0.6705880165100098},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5237950086593628},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.5093127489089966},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5045772790908813},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4257954955101013},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2950930595397949},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.17008137702941895},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.08083844184875488},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009471","descriptor_name":"Neuromyelitis Optica","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009471","descriptor_name":"Neuromyelitis Optica","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014943","descriptor_name":"Global Health","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/13524585231179108","doi":"https://doi.org/10.1177/13524585231179108","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585231179108","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585231179108?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},{"id":"pmid:37300419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37300419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis (Houndmills, Basingstoke, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/13524585231179108","doi":"https://doi.org/10.1177/13524585231179108","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585231179108","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585231179108?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"},{"display_name":"Reduced inequalities","score":0.4074000120162964,"id":"https://metadata.un.org/sdg/10"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4380152962.pdf","grobid_xml":"https://content.openalex.org/works/W4380152962.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W2053472907","https://openalex.org/W2131967919","https://openalex.org/W2898582904","https://openalex.org/W2943416206","https://openalex.org/W2972221943","https://openalex.org/W2977551354","https://openalex.org/W2991438804","https://openalex.org/W3010038365","https://openalex.org/W3018886418","https://openalex.org/W3038660078","https://openalex.org/W3091749440","https://openalex.org/W3205130442","https://openalex.org/W4200226786","https://openalex.org/W4214602716","https://openalex.org/W4223417430","https://openalex.org/W4223530293","https://openalex.org/W4295088386"],"related_works":["https://openalex.org/W2148013305","https://openalex.org/W3135211702","https://openalex.org/W2408642273","https://openalex.org/W1720709409","https://openalex.org/W3044186168","https://openalex.org/W2401569522","https://openalex.org/W2884791875","https://openalex.org/W1537898673","https://openalex.org/W2103528027","https://openalex.org/W4310052027"],"abstract_inverted_index":{"The":[0],"standard":[1],"of":[2,54,65],"care":[3],"for":[4,44,49,75,86],"patients":[5],"with":[6],"neuromyelitis":[7],"optica":[8],"(NMO)":[9],"has":[10],"become":[11],"highly":[12],"unequal":[13],"globally.":[14],"Sufficient":[15],"data":[16],"have":[17],"been":[18],"published":[19],"to":[20,73],"demonstrate":[21],"that":[22],"NMO":[23,48,55,91],"is":[24,57],"a":[25,63],"disabling-and":[26],"at":[27],"times,":[28],"fatal-disease":[29],"needing":[30],"preventive":[31],"immunosuppressive":[32],"treatment.":[33],"Since":[34],"2019,":[35],"there":[36],"are":[37,95],"multiple":[38],"regulatory":[39],"authority-approved":[40],"disease-modifying":[41],"therapies":[42],"(DMTs)":[43],"aquaporin-4":[45],"antibody":[46],"seropositive":[47],"patients.":[50],"Reframing":[51],"the":[52],"picture":[53],"globally":[56],"now":[58],"needed.":[59],"When":[60],"considered":[61],"as":[62],"disease":[64],"high":[66],"mortality":[67],"when":[68],"left":[69],"untreated,":[70],"parallel":[71],"programs":[72],"those":[74],"cancer,":[76],"HIV/AIDS,":[77],"or":[78],"tuberculosis":[79],"can":[80],"be":[81],"considered.":[82],"Nine":[83],"collective":[84],"goals":[85],"rectifying":[87],"global":[88],"inequities":[89],"in":[90],"diagnosis":[92],"and":[93],"treatment":[94],"proposed.":[96]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-06-11T00:00:00"}